01 1Changzhou Pharmaceutical Factory
01 1POMALIDOMIDE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-02-06
Pay. Date : 2024-11-27
DMF Number : 39069
Submission : 2023-10-26
Status : Active
Type : II
20
Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is POMALIDOMIDE, with a corresponding US DMF Number 39069.
Remarkably, this DMF maintains an Active status since its submission on October 26, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 06, 2025, and payment made on November 27, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
